Do Not Miss the (Genetic) Diagnosis of Gaucher Syndrome: A Narrative Review on Diagnostic Clues and Management in Severe Prenatal and Perinatal-Lethal Sporadic Cases

With a growing number of proved therapies and clinical trials for many lysosomal storage disorders (LSDs), a lot of hope for many patients and families exists. However, there are sometimes cases with poor prognosis, fatal outcomes when our efforts must be directed towards a prompt and correct genetic diagnosis, which offers the only possibility of providing the family with appropriate prevention and treatment. To address this issue, in this article, we present the clinical and genetic hallmarks of the lethal form of Gaucher disease (PLGD) and discuss the potential management. We hope that this will draw attention to its specific manifestations (such as collodion-baby phenotype, ichthyosis, arthrogryposis), which differ from best-known GD complications and ensure appropriate diagnostic assessment to provide families at risk with reliable counselling and treatment to avoid the medical complication of GD.

[1]  L. Giordano,et al.  Perinatal‐lethal Gaucher disease presenting with blueberry muffin lesions , 2021, Pediatric dermatology.

[2]  C. Ferreira,et al.  Lysosomal storage disorders as an etiology of nonimmune hydrops fetalis: A systematic review , 2021, Clinical genetics.

[3]  A. Emelyanov,et al.  Ambroxol increases glucocerebrosidase (GCase) activity and restores GCase translocation in primary patient-derived macrophages in Gaucher disease and Parkinsonism. , 2021, Parkinsonism & related disorders.

[4]  Liping Wei,et al.  A Neonatal Case With Perinatal Lethal Gaucher Disease Associated With Missense G234E and H413P Heterozygous Mutations , 2019, Front. Pediatr..

[5]  Christos Proukakis,et al.  Evaluation of the detection of GBA missense mutations and other variants using the Oxford Nanopore MinION , 2019, Molecular genetics & genomic medicine.

[6]  S. Phadke,et al.  Biochemical and molecular characterization of adult patients with type I Gaucher disease and carrier frequency analysis of Leu444Pro - a common Gaucher disease mutation in India , 2018, BMC Medical Genetics.

[7]  F. Lamari,et al.  Metabolic causes of nonimmune hydrops fetalis: A next-generation sequencing panel as a first-line investigation. , 2018, Clinica chimica acta; international journal of clinical chemistry.

[8]  S. Petersen,et al.  Perinatal Lethal Gaucher Disease due to RecNcil Recombinant Mutation in the GBA Gene Presenting with Hydrops Fetalis and Severe Congenital Anemia , 2018, Case reports in pathology.

[9]  A. Schapira,et al.  The L444P Gba1 mutation enhances alpha-synuclein induced loss of nigral dopaminergic neurons in mice , 2017, Brain : a journal of neurology.

[10]  Zayd M. Khaliq,et al.  A New Glucocerebrosidase Chaperone Reduces α-Synuclein and Glycolipid Levels in iPSC-Derived Dopaminergic Neurons from Patients with Gaucher Disease and Parkinsonism , 2016, The Journal of Neuroscience.

[11]  A. Miled,et al.  Gaucher Disease: Clinical, Biological and Therapeutic Aspects , 2015, Pathobiology.

[12]  I. Ouertani,et al.  Perinatal-lethal Gaucher disease presenting as hydrops fetalis , 2015, The Pan African medical journal.

[13]  M. D. Del Bigio,et al.  Atypical features in a case of lethal perinatal Gaucher disease. , 2014, Neuropathology and applied neurobiology.

[14]  C. Rosano,et al.  Functional analysis of 11 novel GBA alleles , 2013, European Journal of Human Genetics.

[15]  Evan W. Matshes,et al.  Gaucher Disease with Prenatal Onset and Perinatal Death Due to Compound Heterozygosity for the Missense R131C and Null RecNciI GBA Mutations , 2011, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[16]  D. Grinberg,et al.  Perinatal lethal form of Gaucher disease. Clinical and molecular characterization of a Greek case. , 2010, Blood cells, molecules & diseases.

[17]  P. Briones,et al.  An update on the molecular analysis of classical galactosaemia patients diagnosed in Spain and Portugal: 7 new mutations in 17 new families. , 2009, Medicina clinica.

[18]  E. Sidransky,et al.  Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA) , 2008, Human mutation.

[19]  P. Macleod,et al.  Perinatal lethal Gaucher’s disease without prenatal complications , 2007, Clinical genetics.

[20]  P. Josset,et al.  Perinatal‐lethal Gaucher disease , 2003, American journal of medical genetics. Part A.

[21]  Ellen Sidransky,et al.  Reciprocal and nonreciprocal recombination at the glucocerebrosidase gene region: implications for complexity in Gaucher disease. , 2003, American journal of human genetics.

[22]  B. Cormand,et al.  Gene rearrangements in the glucocerebrosidase-metaxin region giving rise to disease-causing mutations and polymorphisms. Analysis of 25 RecNciI alleles in Gaucher disease patients , 2003, Human Genetics.

[23]  V. Scheinker,et al.  Analysis of human acid beta-glucosidase by site-directed mutagenesis and heterologous expression. , 1994, The Journal of biological chemistry.

[24]  G. Baydakova,et al.  [Perinatal lethal Gaucher disease. Case report]. , 2021, Arkhiv patologii.

[25]  N. Uraş,et al.  A newborn case with perinatal-lethal Gaucher disease due to R463H homozygosity complicated by C677T homozygosity in the MTHFR gene , 2011, Journal of pediatric endocrinology & metabolism : JPEM.